PARP14
Protein mono-ADP-ribosyltransferase PARP14
Also known as: ARTD8, BAL2, KIAA1268, PAR14_HUMAN, pART8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q460N5
- Gene
- PARP14
- Ensembl
- ENSG00000173193
- Chromosome
- 3
- Canonical length
- 1801 aa
- Protein class
- Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the poly(ADP-ribose) polymerase (PARP) protein family. The encoded anti-apoptotic protein may regulate aerobic glycolysis and promote survival of cancer cells. Increased expression of this gene has been reported in a variety of tumor types. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
1801 residues, UniProt reviewed canonical sequence.
>Q460N5|PARP14
1 MAVPGSFPLL VEGSWGPDPP KNLNTKLQMY FQSPKRSGGG ECEVRQDPRS PSRFLVFFYP
61 EDVRQKVLER KNHELVWQGK GTFKLTVQLP ATPDEIDHVF EEELLTKESK TKEDVKEPDV
121 SEELDTKLPL DGGLDKMEDI PEECENISSL VAFENLKANV TDIMLILLVE NISGLSNDDF
181 QVEIIRDFDV AVVTFQKHID TIRFVDDCTK HHSIKQLQLS PRLLEVTNTI RVENLPPGAD
241 DYSLKLFFEN PYNGGGRVAN VEYFPEESSA LIEFFDRKVL DTIMATKLDF NKMPLSVFPY
301 YASLGTALYG KEKPLIKLPA PFEESLDLPL WKFLQKKNHL IEEINDEMRR CHCELTWSQL
361 SGKVTIRPAA TLVNEGRPRI KTWQADTSTT LSSIRSKYKV NPIKVDPTMW DTIKNDVKDD
421 RILIEFDTLK EMVILAGKSE DVQSIEVQVR ELIESTTQKI KREEQSLKEK MIISPGRYFL
481 LCHSSLLDHL LTECPEIEIC YDRVTQHLCL KGPSADVYKA KCEIQEKVYT MAQKNIQVSP
541 EIFQFLQQVN WKEFSKCLFI AQKILALYEL EGTTVLLTSC SSEALLEAEK QMLSALNYKR
601 IEVENKEVLH GKKWKGLTHN LLKKQNSSPN TVIINELTSE TTAEVIITGC VKEVNETYKL
661 LFNFVEQNMK IERLVEVKPS LVIDYLKTEK KLFWPKIKKV NVQVSFNPEN KQKGILLTGS
721 KTEVLKAVDI VKQVWDSVCV KSVHTDKPGA KQFFQDKARF YQSEIKRLFG CYIELQENEV
781 MKEGGSPAGQ KCFSRTVLAP GVVLIVQQGD LARLPVDVVV NASNEDLKHY GGLAAALSKA
841 AGPELQADCD QIVKREGRLL PGNATISKAG KLPYHHVIHA VGPRWSGYEA PRCVYLLRRA
901 VQLSLCLAEK YKYRSIAIPA ISSGVFGFPL GRCVETIVSA IKENFQFKKD GHCLKEIYLV
961 DVSEKTVEAF AEAVKTVFKA TLPDTAAPPG LPPAAAGPGK TSWEKGSLVS PGGLQMLLVK
1021 EGVQNAKTDV VVNSVPLDLV LSRGPLSKSL LEKAGPELQE ELDTVGQGVA VSMGTVLKTS
1081 SWNLDCRYVL HVVAPEWRNG STSSLKIMED IIRECMEITE SLSLKSIAFP AIGTGNLGFP
1141 KNIFAELIIS EVFKFSSKNQ LKTLQEVHFL LHPSDHENIQ AFSDEFARRA NGNLVSDKIP
1201 KAKDTQGFYG TVSSPDSGVY EMKIGSIIFQ VASGDITKEE ADVIVNSTSN SFNLKAGVSK
1261 AILECAGQNV ERECSQQAQQ RKNDYIITGG GFLRCKNIIH VIGGNDVKSS VSSVLQECEK
1321 KNYSSICLPA IGTGNAKQHP DKVAEAIIDA IEDFVQKGSA QSVKKVKVVI FLPQVLDVFY
1381 ANMKKREGTQ LSSQQSVMSK LASFLGFSKQ SPQKKNHLVL EKKTESATFR VCGENVTCVE
1441 YAISWLQDLI EKEQCPYTSE DECIKDFDEK EYQELNELQK KLNINISLDH KRPLIKVLGI
1501 SRDVMQARDE IEAMIKRVRL AKEQESRADC ISEFIEWQYN DNNTSHCFNK MTNLKLEDAR
1561 REKKKTVDVK INHRHYTVNL NTYTATDTKG HSLSVQRLTK SKVDIPAHWS DMKQQNFCVV
1621 ELLPSDPEYN TVASKFNQTC SHFRIEKIER IQNPDLWNSY QAKKKTMDAK NGQTMNEKQL
1681 FHGTDAGSVP HVNRNGFNRS YAGKNAVAYG KGTYFAVNAN YSANDTYSRP DANGRKHVYY
1741 VRVLTGIYTH GNHSLIVPPS KNPQNPTDLY DTVTDNVHHP SLFVAFYDYQ AYPEYLITFR
1801 KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARP14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- spleen: 26 nTPM
- tonsil: 25 nTPM
- appendix: 23 nTPM
- liver: 23 nTPM
- lymph node: 22 nTPM
- lung: 19 nTPM
Single-cell type
- alveolar cells type 1: 416 nCPM
- transitional alveolar cells: 262 nCPM
- endometrial luminal cells: 253 nCPM
- b-cells: 251 nCPM
- microglia: 230 nCPM
- endometrial ciliated cells: 201 nCPM
Immune cell
- neutrophil: 30 nTPM
- naive B-cell: 20 nTPM
- non-classical monocyte: 15 nTPM
- intermediate monocyte: 14 nTPM
- basophil: 13 nTPM
- memory B-cell: 13 nTPM
Brain region
- medulla oblongata: 38 nTPM
- spinal cord: 29 nTPM
- thalamus: 26 nTPM
- pons: 25 nTPM
- white matter: 23 nTPM
- choroid plexus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 2.63
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- innate immune response
- NAD+ catabolic process
- negative regulation of gene expression
- negative regulation of type II interferon-mediated signaling pathway
- negative regulation of tyrosine phosphorylation of STAT protein
- positive regulation of interleukin-4-mediated signaling pathway
- positive regulation of tyrosine phosphorylation of STAT protein
- protein poly-ADP-ribosylation
Molecular functions
- enzyme binding
- NAD+ binding
- NAD+ poly-ADP-ribosyltransferase activity
- NAD+-protein mono-ADP-ribosyltransferase activity
- NAD+-protein-glutamate ADP-ribosyltransferase activity
- nucleotidyltransferase activity
- transcription corepressor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Macro domain
- WWE domain
- Poly(ADP-ribose) polymerase, catalytic domain
- Nucleotide-binding alpha-beta plait domain superfamily
- WWE domain superfamily
- Macro domain-like
- Mono-ADP-ribosyltransferase ARTD/PARP
- PARP14-like, eighth type I KH domain
- PAR14-like, first RRM domain
- Poly(ADP-ribose) polymerase catalytic domain
- Macro domain
- PARP14, third RRM domain
- PAR14-like, first RRM domain
- PARP14-like, eighth type I KH domain
- PARP-14, RNA recognition motif 2
- Mono-ADP-ribosyltransferase PARP14, WWE domain
- PARP14, second type I KH domain
- PARP14, first type I KH domain
- PARP14, third type I KH domain
- PARP14, fourth type I KH domain
- PARP14, fifth type I KH domain
- PARP14, sixth type I KH domain
- PARP14, second RRM domain
- Parp14 WWE domain
- PARP14, first type I KH domain
- PARP14, second RRM domain
- PARP14, second type I KH domain
- PARP14, third type I KH domain
- PARP14, fourth type I KH domain
- PARP14, fifth type I KH domain
- PARP14, sixth type I KH domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARP14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARP14 as an antibody target. Whether an autoantibody or antibody against PARP14 could matter depends on whether native PARP14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARP14 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PARP14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...